- Home
- CMPX vs AEVA Comparison
CMPX vs AEVA Comparison
Compare CMPX & AEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CMPX | AEVA |
|---|---|---|
| Founded | 2014 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 752.4M | 600.2M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | CMPX | AEVA |
|---|---|---|
| Price | $5.05 | $14.38 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 4 |
| Target Price | $13.44 | ★ $26.50 |
| AVG Volume (30 Days) | ★ 2.2M | 2.1M |
| Earning Date | 11-05-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $15,154,000.00 |
| Revenue This Year | N/A | $87.44 |
| Revenue Next Year | N/A | $70.49 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 89.90 |
| 52 Week Low | $1.33 | $2.52 |
| 52 Week High | $5.86 | $38.80 |
Technical Indicators
Market Signals| Indicator | CMPX | AEVA |
|---|---|---|
| Relative Strength Index (RSI) | 49.43 | 52.77 |
| Support Level | $4.83 | $12.83 |
| Resistance Level | $5.32 | $17.33 |
| Average True Range (ATR) | 0.31 | 1.43 |
| MACD | -0.09 | 0.05 |
| Stochastic Oscillator | 16.76 | 55.92 |
Price Performance
Historical ComparisonAbout CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.
About AEVA Aeva Technologies Inc.
Aeva Technologies Inc through its Frequency Modulated Continuous Wave (FMCW) sensing technology, designs a 4D LiDAR-on-chip that, along with its proprietary software applications, has the potential to enable the adoption of LiDAR across broad applications from automated driving to consumer electronics, consumer health, industrial automation, and security application. The company operates in North America, EMEA, and Asia. The company derives the majority of its revenue from North America.